Overview
JSPR market data
Price History
JSPR price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$3.95 Diluted earnings per share over the trailing twelve months.
- Beta
- 3.25 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $0.32 – $3.14 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $24.5M · P/B 12.34.
Company News
Piper Sandler Initiates Coverage On Jasper Therapeutics with Overweight Rating, Announces Price Target of $2Benzinga · Aug 12, 2026, 9:21 AM
12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga · Aug 11, 2026, 5:06 PM
Deal Dispatch: Uber Buys Delivery Hero For $14.8 Billion, Eli Lilly Acquires AtaiBeckley, Lulu’s Fashion Considers Strategic AlternativesBenzinga · Jul 17, 2026, 5:18 PM
Jasper Closes Kira Deal, Extends Cash RunwayBenzinga · Jul 17, 2026, 5:08 PM
Jasper Therapeutics shares are trading lower after the company announced it completed the acquisition of Kira Pharmaceuticals.Benzinga · Jul 17, 2026, 1:10 PM
Why Callan JMB Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving PremarketBenzinga · Jul 17, 2026, 8:48 AM
Trading Halt: Halt status updated at 5:40:00 PM ET: Quotation Resumption: News and Resumption TimesBenzinga · Jul 16, 2026, 9:40 PM
Jasper Therapeutics Completes The Acquisition Of Kira Pharmaceuticals; Announces $132M Private Placement Of Convertible Preferred Stock; Combined Company Operations Expected To Be Funded Through Second Half Of 2028Benzinga · Jul 16, 2026, 9:18 PM
Jasper Therapeutics Received Notice Of Non-Compliance With Nasdaq Minimum Bid Requirements On June 3Benzinga · Jun 9, 2026, 8:10 PM
Deal Dispatch: Jasper Therapeutics For Sale, RobinHood Completes $180 Million WonderFi Acquisition, Long John Silver's Franchisee To LiquidateBenzinga · Jun 5, 2026, 6:15 PM